Outcome |
Acute leukemia/BMT |
Solid organ cancer/lymphoma |
||
---|---|---|---|---|
Any AB | Quinolone | Any AB | Quinolone | |
All cause mortality | 0.67 (0.55–0.83) | 0.58 (040–0.84) | 0.58 (0.33–1.00 | 0.48 (0.26–0.85) |
Febrile neutropenia | 0.80 (0.77–0.84) | 0.77 (073–0.82) | 0.65 (0.55–0.77 | 0.67 (0.57–0.80) |
Clinically documented infections | 0.76 (0.69–0.84) | 0.75 (064–0.89) | 0.59 (0.47–0.73) | 0.61 (0.48–0.76) |
Any bacteremia | 0.55 (0.40–0.62) | 0.62 (0 53–0.73) | 0.32 (0.17–0.61 | 0.36 (0.18–0.70) |
Gram-negative bacteremia | 0.44 (0.35–0 56) | 0.36 (0 25–0.50) | 0.29 (0.10–0.88) | 0.32 (0.09–1.18) |
Gram-positive bacteremia | 0.71 (0.59–0.86) | 0.81 (0 65–1.01) | 0.32 (0.12–0.89) | 0.35 (0.12–1.04) |
Infection-related mortality | 0.62 (0.48–0.80) | 0.51 (0 31–0.84) | 0.65 (0.29–1.46) | 0.41 (0.14–1.14) |
Relative risks with 95% confidence intervals; AB – antibiotic